🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The early clinical development paradigm for chemotherapeutic agents has sig...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2015-12-03
Trial ID
NCT02510950
Treatments Being Tested
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
The purpose of this study is to test the safety of a course of injections c...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2013-11
Trial ID
NCT01984892
Treatments Being Tested
The purpose of this study is to determine whether the combination of a neoa...
Status
Not Yet Recruiting
Location
Johns Hopkins SKCCC
Start Date
2026-09
Trial ID
NCT07430202
Treatments Being Tested
This is a multi-center, randomized, double-blind clinical trial to assess t...
Status
Completed
Location
University of Maryland Greenebaum Cancer Center
Start Date
2017-03-30
Trial ID
NCT02873819
Treatments Being Tested
This is a partially blinded randomized controlled phase II pilot study comp...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai (ISMMS)
Start Date
2024-01-16
Trial ID
NCT06343077
Treatments Being Tested
This research study is evaluating a new type of vaccine called "Personalize...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2020-11-20
Trial ID
NCT04024878
Treatments Being Tested
This is a phase 1b study of P30-linked EphA2, CMV pp65, and survivin vaccin...
Status
Active Not Recruiting
Location
The Preston Robert Tisch Brain Tumor Center at Duke University
Start Date
2023-08-30
Trial ID
NCT05283109
Treatments Being Tested
This is an open-label, multicenter, Phase 1/2 study of the CTLA-4 antibody,...
Status
Completed
Location
Research Facility
Start Date
2016-12-28
Trial ID
NCT02643303
Treatments Being Tested
The purpose of this study is to evaluate the safety and the immune response...
Status
Recruiting
Location
SKCCC Johns Hopkins Medical Institution
Start Date
2025-05-27
Trial ID
NCT06564623
Treatments Being Tested